IRBESARTAN for Secondary progressive multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 12 adverse event reports in the FDA FAERS database where IRBESARTAN was used for Secondary progressive multiple sclerosis.
Most Reported Side Effects for IRBESARTAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Acute kidney injury | 1,361 | 13.4% | 73 | 1,049 |
| Fall | 795 | 7.8% | 30 | 678 |
| Hypotension | 686 | 6.8% | 10 | 483 |
| Nausea | 533 | 5.3% | 11 | 387 |
| Drug ineffective | 532 | 5.2% | 6 | 114 |
| Malaise | 488 | 4.8% | 15 | 332 |
| Hyponatraemia | 485 | 4.8% | 4 | 461 |
| Fatigue | 483 | 4.8% | 12 | 295 |
| Blood pressure increased | 477 | 4.7% | 0 | 216 |
| Hyperkalaemia | 454 | 4.5% | 24 | 295 |
| Cough | 438 | 4.3% | 0 | 252 |
| Asthenia | 408 | 4.0% | 3 | 304 |
| Headache | 406 | 4.0% | 6 | 216 |
| Confusional state | 400 | 3.9% | 0 | 349 |
| Dizziness | 399 | 3.9% | 1 | 173 |
Other Indications for IRBESARTAN
Hypertension (5,190)
Product used for unknown indication (2,746)
Blood pressure measurement (107)
Blood pressure abnormal (87)
Essential hypertension (75)
Abdominal discomfort (73)
Cardiac failure (63)
Blood pressure (42)
Suicide attempt (36)
Blood pressure increased (34)
Other Drugs Used for Secondary progressive multiple sclerosis
SIPONIMOD (2,265)
OCRELIZUMAB (1,273)
OFATUMUMAB (1,099)
FINGOLIMOD (351)
INTERFERON BETA-1B (146)
RITUXIMAB (131)
NATALIZUMAB (115)
DIMETHYL (96)
INTERFERON BETA-1A (89)
RABEPRAZOLE (86)